Show simple item record

dc.contributor.authorDEV, KUMLESHen
dc.date.accessioned2014-08-01T15:39:50Z
dc.date.available2014-08-01T15:39:50Z
dc.date.issued2014en
dc.date.submitted2014en
dc.identifier.citationPritchard, AJ, Mir, AK, Dev, KK, Fingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Cultures, PLOS ONE, 9, 6, 2014, 0099444-en
dc.identifier.otherYen
dc.identifier.urihttp://hdl.handle.net/2262/70661
dc.descriptionPUBLISHEDen
dc.description.abstractThe family of sphingosine-1-phosphate receptors (S1PRs) is G-protein-coupled, comprised of subtypes S1PR1-S1PR5 and activated by the endogenous ligand S1P. The phosphorylated version of Fingolimod (pFTY720), an oral therapy for multiple sclerosis (MS), induces S1PR1 internalisation in T cells, subsequent insensitivity to S1P gradients and sequestering of these cells within lymphoid organs, thus limiting immune response. S1PRs are also expressed in neuronal and glial cells where pFTY720 is suggested to directly protect against lysolecithin-induced deficits in myelination state in organotypic cerebellar slices. Of note, the effect of pFTY720 on immune cells already migrated into the CNS, prior to treatment, has not been well established. We have previously found that organotypic slice cultures do contain immune cells, which, in principle, could also be regulated by pFTY720 to maintain levels of myelin. Here, a mouse organotypic cerebellar slice and splenocyte co-culture model was thus used to investigate the effects of pFTY720 on splenocyte-induced demyelination. Spleen cells isolated from myelin oligodendrocyte glycoprotein immunised mice (MOG-splenocytes) or from 2D2 transgenic mice (2D2-splenocytes) both induced demyelination when co-cultured with mouse organotypic cerebellar slices, to a similar extent as lysolecithin. As expected, in vivo treatment of MOG-immunised mice with FTY720 inhibited demyelination induced by MOG-splenocytes. Importantly, in vitro treatment of MOG- and 2D2-splenocytes with pFTY720 also attenuated demyelination caused by these cells. In addition, while in vitro treatment of 2D2-splenocytes with pFTY720 did not alter cell phenotype, pFTY720 inhibited the release of the pro-inflammatory cytokines such as interferon gamma (IFNγ) and interleukin 6 (IL6) from these cells. This work suggests that treatment of splenocytes by pFTY720 attenuates demyelination and reduces pro-inflammatory cytokine release, which likely contributes to enhanced myelination state induced by pFTY720 in organotypic cerebellar slices.en
dc.format.extent0099444en
dc.language.isoenen
dc.relation.ispartofseriesPLOS ONEen
dc.relation.ispartofseries9en
dc.relation.ispartofseries6en
dc.rightsYen
dc.subjectSpleenen
dc.subjectRegulatory T cellsen
dc.subjectMultiple sclerosisen
dc.subjectImmune cellsen
dc.subjectCytokinesen
dc.subjectCell stainingen
dc.subjectAnalysis of varianceen
dc.titleFingolimod Attenuates Splenocyte-Induced Demyelination in Cerebellar Slice Culturesen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/devken
dc.identifier.rssinternalid95750en
dc.identifier.doihttp://dx.doi.org/10.1371/journal.pone.0099444en
dc.rights.ecaccessrightsopenAccess


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record